Emcure Pharmaceuticals Q1 profit rises 36% at ₹292.5 crore

Q1FY27 profit rises 36% on robust overseas growth, operating gains. Emcure Pharmaceuticals reported a 36.2% YoY rise in Q1 FY27 net profit to Rs 292 crore, with revenue up 22.8% at Rs 2,580 crore and EBITDA margin expanding to 19.7%. International business grew 34.2%, driving 58% of revenue. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.